WASHINGTON, 22nd April, 2026 (WAM) -- Researchers have found that slowing ageing may not be linked to dietary restriction as previously believed, but rather to regulating the activity of an immune ...

Yale researchers have previously shown that people who undergo moderate calorie restriction—a 14% reduction in calorie intake ...

Apellis Pharmaceuticals’ long-term GALE study found that Syfovre (pegcetacoplan) delayed geographic atrophy lesion growth by about 1.5 years over five years compared with sham treatment. The therapy, ...

New targeted therapies are transforming treatment for rare kidney disorders, offering hope of slowing disease progression and ...

Objective Cardiovascular diseases are a leading cause of morbidity and mortality in SLE. In this target population, ...

Distinct circulating and hepatic molecular signatures appear to track metabolic dysfunction-associated steatotic liver ...

Outcomes After Minor Ischemic Stroke in Older Patients Treated With IV Thrombolysis vs Standard of Care in the TEMPO-2 Trial ...

The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...

In recent years, the complement system has been implicated in the pathophysiology and progression of many disorders, notably modulating inflammation and causing endothelial and organ damage 1. Acute ...

The authors examined experiences with Pennsylvania’s implementation of opioid settlement funds, identifying 7 themes and ...

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, ...